World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
49
Citations
10291
World Ranking
5929
National Ranking
90

Antonio Gil-Nagel publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Antonio Gil-Nagel sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 235 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Antonio Gil-Nagel D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Antonio Gil-Nagel sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 49 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Antonio Gil-Nagel is affiliated with Hospital Ruber Internacional in Spain and has contributed extensively to research in the fields of medicine and neuroscience, with a particular focus on epilepsy research and treatment. Their publication record includes significant work in areas such as pharmacological effects, neuropharmacology, genetics, and neurodevelopmental disorders.

The main fields of study for Antonio Gil-Nagel include:

  • Medicine
  • Neuroscience

Their subfields of study cover a range of disciplines related to brain science and health:

  • Psychiatry and Mental health
  • Pediatrics, Perinatology and Child Health
  • Cellular and Molecular Neuroscience
  • Cognitive Neuroscience
  • Genetics

Antonio Gil-Nagel's research frequently addresses topics such as:

  • Epilepsy research and treatment
  • Pharmacological Effects and Toxicity Studies
  • Neuroscience and Neuropharmacology Research
  • Genetics and Neurodevelopmental Disorders
  • Metabolism and Genetic Disorders
  • EEG and Brain-Computer Interfaces
  • Neonatal and fetal brain pathology

The scientist has been published multiple times in various academic venues that focus on epilepsy and neurological study. These include:

  • Epilepsy & Behavior
  • Neurology
  • Epilepsia
  • Seizure
  • Epilepsia Open

Antonio Gil-Nagel has collaborated with a number of coauthors on numerous projects, some of the most frequent being:

  • Rafael Toledano
  • Ángel Aledo-Serrano
  • Irene García-Morales
  • Lieven Lagae
  • Álvaro Beltrán-Corbellini

Notable recent papers authored or coauthored by Antonio Gil-Nagel include:

  • Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study, 2020, The Lancet Neurology
  • Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome, 2020, JAMA Neurology
  • Epilepsy and cannabidiol: a guide to treatment., 2020, PubMed
  • The burden of epilepsy and unmet need in people with focal seizures, 2022, Brain and Behavior
  • Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome, 2022, JAMA Neurology

Best Publications

  • Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery.

    Blumcke I;Spreafico R;Haaker G;Coras R

  • A fast pathway for fear in human amygdala

    Constantino Méndez-Bértolo;Stephan Moratti;Stephan Moratti;Rafael Toledano;Fernando Lopez-Sosa

  • Mutations in the Gene Encoding KRIT1, a Krev-1/rap1a Binding Protein, Cause Cerebral Cavernous Malformations (CCM1)

    Trilochan Sahoo;Eric W. Johnson;James W. Thomas;Peter M. Kuehl

  • Seizure control and treatment in pregnancy: Observations from the EURAP epilepsy pregnancy registry

    Torbjörn Tomson;D. Battino;E. Bonizzoni;J. Craig

  • Seizure outcome and use of antiepileptic drugs after epilepsy surgery according to histopathological diagnosis: a retrospective multicentre cohort study

    Herm J Lamberink;Willem M Otte;Ingmar Blümcke;Kees P J Braun

  • Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy

    M.J. Brodie;H. Lerche;A. Gil-Nagel;C. Elger

  • Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial.

    Ian Miller;Ingrid E Scheffer;Boudewijn Gunning;Rocio Sanchez-Carpintero

  • Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest

    Eric W. Johnson;Jan Dubovsky;Stephen S. Rich;Cormac A. O'Donovan

  • Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.

    Rima Nabbout;Arun Mistry;Sameer Zuberi;Nathalie Villeneuve

  • Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.

    A. Gil-Nagel;J. Lopes-Lima;L. Almeida;L. Almeida;J. Maia

  • Ictal semiology in hippocampal versus extrahippocampal temporal lobe epilepsy.

    Unknown

  • Epidemiological profile of epilepsy in low income populations.

    Camilo Espinosa-Jovel;Rafael Toledano;Ángel Aledo-Serrano;Irene García-Morales

  • Antiepileptic drug therapy: Does mechanism of action matter?

    Martin J. Brodie;Athanasios Covanis;Antonio Gil-Nagel;Holger Lerche

  • Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome

    Unknown

  • The burden of epilepsy and unmet need in people with focal seizures

    Unknown

  • Current standards of neuropsychological assessment in epilepsy surgery centers across Europe

    Viola Lara Vogt;Marja Äikiä;Antonio del Barrio;Paul Boon

  • Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Frontal Lobe Epilepsy: A New Clinico-Pathological Entity.

    Johannes Schurr;Roland Coras;Karl Rössler;Tom Pieper

  • Epilepsy and Cannabidiol: A Guide to Treatment

    Alexis Arzimanoglou;Ulrich Brandl;J Helen Cross;Antonio Gil-Nagel

  • Effect of lamotrigine on sexual function in patients with epilepsy

    A. Gil-Nagel;F. López-Muñoz;J.M. Serratosa;I. Moncada

  • Strategies to detect adverse effects of antiepileptic drugs in clinical practice

    M. Carreño;A. Gil-Nagel;J.C. Sánchez;E. Elices

  • Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe.

    Brian E. Mouthaan;Matea Rados;Péter Barsi;Paul Boon

  • Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials

    Victor Biton;Antonio Gil-Nagel;Jouko Isojarvi;Pamela Doty

  • Adverse effects of antiepileptic drugs.

    Rafael Toledano;Antonio Gil-Nagel

  • Current practices in long-term video-EEG monitoring services: A survey among partners of the E-PILEPSY pilot network of reference for refractory epilepsy and epilepsy surgery.

    Teia Kobulashvili;Julia Höfler;Judith Dobesberger;Florian Ernst

Frequent Co-Authors

José M. Serratosa
José M. Serratosa Hospital Universitario Fundación Jiménez Díaz
Ingmar Blümcke
Ingmar Blümcke University of Erlangen-Nuremberg
Eugen Trinka
Eugen Trinka Paracelsus Medical University
Bernhard J. Steinhoff
Bernhard J. Steinhoff University of Göttingen
Kristina Malmgren
Kristina Malmgren University of Gothenburg
Philippe Ryvlin
Philippe Ryvlin University Hospital of Lausanne
Hajo M. Hamer
Hajo M. Hamer University of Erlangen-Nuremberg
Kees P.J. Braun
Kees P.J. Braun Utrecht University
Felix Rosenow
Felix Rosenow Goethe University Frankfurt
Fernando Maestú
Fernando Maestú Complutense University of Madrid

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Neuroscience is a dynamic and interdisciplinary field. If you are considering related academic options, several interesting majors that pay well can complement your studies and enhance your career prospects, such as biomedical engineering, computer science, or psychology.

Many students now choose flexible learning formats. Numerous fafsa-approved online certificate programs make it easier to start or advance your education affordably. These programs also allow you to specialize in areas such as neuropsychology or data analysis.

You might also explore online certification courses in related fields like healthcare, data science, or clinical research. Such certificates can enhance your resume and are often designed to be completed quickly.

Finally, students new to online study may want to consider easy bachelor degrees online as a first step. These programs can build foundational skills or offer stepping stones into more advanced neuroscience degrees and rewarding career pathways.

Best Scientists Citing Antonio Gil-Nagel

Trending Scientists

Recently Published Articles